Elsevier’s Oncology Journal Network Highlights | Elsevier
Welcome to our Elsevier’s Oncology Journal Network Highlights page
Welcome to our Elsevier’s Oncology Journal Network Highlights page
Researchers analyzed the surgical stress response and tissue trauma in patients with NSCLC after robot-assisted and video-assisted procedures using leukocyte count as a surrogate measure.
How long does it take for chemotherapy to start shrinking a tumor? Head and neck specialist and thoracic medical oncologist Janet Tu, M.D., weighs in.
The primary end point of overall survival was met in the KEYNOTE-811 trial assessing pembrolizumab in HER2-positive gastrointestinal cancer.
Hundreds of cancer patients in northwestern Arkansas have access to free transportation to treatment centers thanks to Hope Cancer Resources.
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
New study results show test using exosomes has high accuracy in identifying the hard-to-detect disease at its onset
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
Funding is urgently needed to support end-of-life care for patients in hospices across the UK, according to general consensus during a parliamentary debate in the…
An interim analysis of the Australian phase II ENZA-p trial showed that the addition of lutetium-177–labeled PSMA-617 (LuPSMA) to enzalutamide improved prostate-specific antigen progression-free survi…
According to results from the phase 2 Natalie trial, cabozantinib showed promising clinical activity among patients with progressive, unresectable metastatic phaeochromocytomas and paragangliomas.